Bausch Health Companies (BHC) EBITDA Margin Growth (1y) (2010 - 2026)
Bausch Health Companies (BHC) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.56 Bn | 725.13 Mn | 2.10 Bn | 840.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 840.00 |
| Mar 31, 2026 | -4,986.00 |
| Dec 31, 2025 | -485.00 |
| Sep 30, 2025 | 1,042.00 |
| Jun 30, 2025 | 136.00 |
| Mar 31, 2025 | -83.00 |
| Dec 31, 2024 | 677.00 |
| Sep 30, 2024 | 1,204.00 |
| Jun 30, 2024 | -282.00 |
| Mar 31, 2024 | 405.00 |
| Dec 31, 2023 | 2,579.00 |
| Sep 30, 2023 | -1,130.00 |
| Jun 30, 2023 | 1,083.00 |
| Mar 31, 2023 | -586.00 |
| Dec 31, 2022 | -1,583.00 |
| Sep 30, 2022 | -1,527.00 |
| Jun 30, 2022 | 2,104.00 |
| Mar 31, 2022 | 2,576.00 |
| Dec 31, 2021 | 529.00 |
| Sep 30, 2021 | 568.00 |